Related Experiment Video
Updated: Jan 2, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Incidence of adverse reactions to vaccines in a paediatric population
Pilar Carrasco-Garrido1, Carmen Gallardo-Pino, Rodrigo Jiménez-García
1Preventive Medicine and Public Health Teaching and Research Unit, Faculty of Health Sciences, Rey Juan Carlos University, Alcorcón, Spain.
Insights
This study detected non-serious adverse reactions in 19% of children receiving vaccines, with the diphtheria, tetanus, pertussis acellular and Haemophilus influenzae type b (DTPa + Hib) vaccine most frequently implicated. Healthcare providers should actively monitor for vaccine side effects in pediatric populations.
Area of Science:
- Pediatric Vaccinology
- Epidemiological Studies
- Public Health
Background:
- Vaccine safety monitoring is crucial for public trust and informed decision-making.
- Understanding the spectrum of adverse reactions in children is essential for healthcare providers.
- Previous studies may not capture all vaccine-related adverse events in pediatric populations.
Purpose of the Study:
- To actively detect and characterize adverse reactions following vaccination in a pediatric cohort.
- To identify specific vaccine types associated with common adverse events.
- To inform healthcare professionals about potential vaccine side effects in children.
Main Methods:
- A 6-month prospective, observational, multicenter study involving 946 children aged 0-14 years.
- Two-phase telephone surveys conducted at 1 week and 30 days post-vaccination.
- Adverse reactions were diagnosed by a pediatrician.
Main Results:
- 191 non-serious adverse reactions were reported in 19% of vaccinated children.
- The diphtheria, tetanus, pertussis acellular and Haemophilus influenzae type b (DTPa + Hib) vaccine was associated with the highest percentage of reactions (43.4%).
- Common reactions included injection-site edema, pain, and fever; the measles, mumps, rubella (MMR) vaccine was linked to fever.
Conclusions:
- Active surveillance effectively identifies adverse vaccine reactions often underreported in routine practice.
- Primary care physicians and nurses play a vital role in vigilant monitoring and reporting of vaccine side effects.
- Findings underscore the importance of ongoing pharmacovigilance in pediatric vaccination programs.
Objective:
To detect the appearance and specify the types of adverse reactions to vaccines registered in a paediatric population.
Patients And Methods:
A 6-month, prospective, observational, multicentre epidemiological vaccine safety study was undertaken in 2002 covering a paediatric population subject to vaccine administration. A two-phase telephone survey of all patients was conducted, comprising an initial call at 1 week and a follow-up call at 30 days after the vaccine administration date. A paediatrician was responsible for diagnosing the specific type of adverse reaction.
Results:
Of a total sample of 946 children, ranging in age from 0 to 14 years (50.8% girls, 49.1% boys), 191 non-serious suspected adverse reactions were detected, representing 19% of the vaccinated children. Reactions to the diphtheria, tetanus, pertussis acellular and Haemophilus influenzae type b (DTPa + Hib) vaccine appeared in 43.4% of cases, followed by reactions to the measles, mumps, rubella (MMR) [18.4%] and adult tetanus and diphtheria (Td) [17.8%] vaccines. The most frequent types of adverse reactions to vaccines were: injection-site oedema (12.2 per 1000 doses); pain at site of inoculation (10.3 per 1000 doses); temperature not recorded but believed by parents to be very high (4.6 per 1000 doses); and measured temperature indicating fever of 39-40.5 masculineC (4.4 per 1000 doses). Fifty-five percent (n = 21) of cases of injection-site oedema were attributed to DTPa + Hib vaccine (18.8 per 1000 doses), followed by 18.4% (n = 7) attributable to Td vaccine (112 per 1000 doses). Indeed, this latter vaccine was responsible for 43.8% (n = 14; 226 per 1000 doses) of all reported pain at the site of inoculation. MMR vaccine was linked to the occurrence of fever of 39-40.5 masculineC in 52% of cases (n = 10; 29 per 1000 doses). Two children were treated by the emergency services, but there were no deaths or hospitalisations.
Conclusions:
An active search for subjects with suspected adverse reactions to vaccines led to the detection of reactions that are usually not reported. Primary-care physicians and nurses must be vigilant for information on adverse reactions to vaccines in paediatric populations.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Vaccinations
Allergic Reactions